13F

Stock

Keros Therapeutics, Inc.

KROS · held by 1 managers

Reported value

$7.46K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$7.22K

Price effect on 1 books still in the name

Largest holder

$7.46K

Leonteq Securities AG

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Leonteq Securities AG270$7.46K−$7.22KCut−$7.22K

Positions as of Q2 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.